BAJAJ BROKING

Notification
No new Notification messages
Suraksha Diagnostic IPO is Open!
Apply for the Suraksha Diagnostic IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
sakar healthcare limited stock

SAKAR HEALTHCARE LIMITED Share Price

308.8 0.00 (0.00%)
Dec 02 2024 12:00 AM Pharmaceuticals NSE: SAKAR

SAKAR HEALTHCARE LIMITED Share Price Update

As of the latest trading session, SAKAR HEALTHCARE LIMITED share price is currently at 308.8, which is up by 0.00 from its previous closing. Today, the stock has fluctuated between 302.95 and 310.20. Over the past year, SAKAR HEALTHCARE LIMITED has achieved a return of -23.62 %. In the last month alone, the return has been -1.30 %. Read More...

SAKAR HEALTHCARE LIMITED Performance

Day Range

Low302.95 High310.20
308.80

52 Week Range

Low 279.85 High 479.00
308.80

SAKAR HEALTHCARE LIMITED Share Price

9539

SAKAR

img img img img
No Data Available

Open Price

304.40

Prev. Close

308.80

Volume (Shares)

18285.00

Total traded value

56.46

Upper Circuit

370.55

Lower Circuit

247.05

Note: The current prices & values are delayed, Login to your account for live updates.

SAKAR HEALTHCARE LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 671.64
PE Ratio (TTM) 54.18
Book Value / Share 123.91
Beta 0.79
ROE 5.36%
EPS (TTM) 5.70
Dividend Yield 0.00%
Net Profit Qtr (Cr) 4.80

SAKAR HEALTHCARE LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 42.78
Operating Expense 38.04
Net Profit 4.80
Net Profit Margin (%) 11.22
Earnings Per Share (EPS) 2.17
EBITDA 11.87
Effective Tax Rate (%) 6.06
Particulars JUN 2024 (Values in Cr)
Revenue 41.15
Operating Expense 36.91
Net Profit 2.41
Net Profit Margin (%) 5.85
Earnings Per Share (EPS) 1.10
EBITDA 11.16
Effective Tax Rate (%) 48.72
Particulars MAR 2024 (Values in Cr)
Revenue 43.06
Operating Expense 39.04
Net Profit 3.12
Net Profit Margin (%) 7.24
Earnings Per Share (EPS) 1.46
EBITDA 11.75
Effective Tax Rate (%) 34.79
Particulars DEC 2023 (Values in Cr)
Revenue 37.23
Operating Expense 34.44
Net Profit 2.07
Net Profit Margin (%) 5.56
Earnings Per Share (EPS) 0.98
EBITDA 9.23
Effective Tax Rate (%) 31.00
Particulars SEP 2023 (Values in Cr)
Revenue 34.08
Operating Expense 30.59
Net Profit 3.64
Net Profit Margin (%) 10.68
Earnings Per Share (EPS) 1.68
EBITDA 10.02
Effective Tax Rate (%) 12.53
Particulars MAR 2024 (Values in Cr)
Revenue 153.35
Operating Expense 140.63
Net Profit 11.67
Net Profit Margin (%) 7.61
Earnings Per Share (EPS) 5.64
EBITDA 41.54
Effective Tax Rate (%) 26.60
Particulars MAR 2023 (Values in Cr)
Revenue 133.36
Operating Expense 121.15
Net Profit 12.76
Net Profit Margin (%) 9.56
Earnings Per Share (EPS) 6.58
EBITDA 37.82
Effective Tax Rate (%) 24.40
Particulars MAR 2022 (Values in Cr)
Revenue 128.23
Operating Expense 111.39
Net Profit 15.24
Net Profit Margin (%) 11.88
Earnings Per Share (EPS) 8.77
EBITDA 31.58
Effective Tax Rate (%) 19.83
Particulars MAR 2021 (Values in Cr)
Revenue 94.74
Operating Expense 82.67
Net Profit 10.69
Net Profit Margin (%) 11.28
Earnings Per Share (EPS) 6.88
EBITDA 23.78
Effective Tax Rate (%) 19.25
Particulars MAR 2020 (Values in Cr)
Revenue 82.98
Operating Expense 72.77
Net Profit 9.62
Net Profit Margin (%) 11.59
Earnings Per Share (EPS) 6.40
EBITDA 21.56
Effective Tax Rate (%) 21.25
Particulars MAR 2024 (Values in Cr)
Book Value / Share 118.41
ROE % 5.36
ROCE % 7.36
Total Debt to Total Equity 0.46
EBITDA Margin 27.09
Particulars MAR 2023 (Values in Cr)
Book Value / Share 91.04
ROE % 8.48
ROCE % 8.85
Total Debt to Total Equity 0.70
EBITDA Margin 28.35
Particulars MAR 2022 (Values in Cr)
Book Value / Share 74.45
ROE % 13.49
ROCE % 12.05
Total Debt to Total Equity 0.60
EBITDA Margin 24.63
Particulars MAR 2021 (Values in Cr)
Book Value / Share 63.04
ROE % 11.88
ROCE % 13.07
Total Debt to Total Equity 0.33
EBITDA Margin 25.09
Particulars MAR 2020 (Values in Cr)
Book Value / Share 54.35
ROE % 11.83
ROCE % 14.68
Total Debt to Total Equity 0.20
EBITDA Margin 25.99
Particulars MAR 2024 (Values in Cr)
Book Value / Share 118.44
ROE % 5.36
ROCE % 7.36
Total Debt to Total Equity 0.46
EBITDA Margin 27.09
Particulars MAR 2023 (Values in Cr)
Book Value / Share 91.09
ROE % 8.48
ROCE % 8.85
Total Debt to Total Equity 0.70
EBITDA Margin 28.35
Particulars MAR 2022 (Values in Cr)
Book Value / Share 74.50
ROE % 13.49
ROCE % 12.05
Total Debt to Total Equity 0.60
EBITDA Margin 24.63
Particulars MAR 2021 (Values in Cr)
Book Value / Share 63.04
ROE % 11.89
ROCE % 13.07
Total Debt to Total Equity 0.33
EBITDA Margin 25.10
Particulars MAR 2020 (Values in Cr)
Book Value / Share 54.35
ROE % 12.57
ROCE % 15.91
Total Debt to Total Equity 0.18
EBITDA Margin 25.99
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.46
Total Assets 388.65
Total Liabilities 388.65
Total Equity 262.33
Share Outstanding 21750000
Price to Book Ratio 3.11
Return on Assets (%) 3.00
Return on Capital (%) 3.52
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 336.33
Total Liabilities 336.33
Total Equity 173.34
Share Outstanding 19040000
Price to Book Ratio 2.20
Return on Assets (%) 3.79
Return on Capital (%) 4.48
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 267.76
Total Liabilities 267.76
Total Equity 127.46
Share Outstanding 17118000
Price to Book Ratio 1.81
Return on Assets (%) 5.66
Return on Capital (%) 7
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 177.79
Total Liabilities 177.79
Total Equity 98.45
Share Outstanding 15618000
Price to Book Ratio 1.79
Return on Assets (%) 6.00
Return on Capital (%) 7.71
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.29
Total Assets 115.03
Total Liabilities 115.03
Total Equity 81.31
Share Outstanding 14961000
Price to Book Ratio 0.92
Return on Assets (%) 8.36
Return on Capital (%) 10.03
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.46
Total Assets 388.74
Total Liabilities 388.74
Total Equity 262.41
Share Outstanding 21750000
Price to Book Ratio 3.11
Return on Assets (%) 3.00
Return on Capital (%) 3.52
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 336.42
Total Liabilities 336.42
Total Equity 173.43
Share Outstanding 19040000
Price to Book Ratio 2.20
Return on Assets (%) 3.79
Return on Capital (%) 4.48
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 267.84
Total Liabilities 267.84
Total Equity 127.53
Share Outstanding 17118000
Price to Book Ratio 1.81
Return on Assets (%) 5.69
Return on Capital (%) 7.02
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 177.80
Total Liabilities 177.80
Total Equity 98.46
Share Outstanding 15618000
Price to Book Ratio 1.79
Return on Assets (%) 6.01
Return on Capital (%) 7.71
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.29
Total Assets 115.12
Total Liabilities 115.12
Total Equity 81.31
Share Outstanding 14961000
Price to Book Ratio 0.92
Return on Assets (%) 8.35
Return on Capital (%) 10.02
Particulars MAR 2024 (Values in Cr)
Net Income 15.89
Cash from Operations 141.82
Cash from Investing -51.53
Cash from Financing 27.44
Net change in Cash 0.37
Free Cash Flow 201.38
Particulars MAR 2023 (Values in Cr)
Net Income 16.87
Cash from Operations 37.60
Cash from Investing -74.37
Cash from Financing 41.09
Net change in Cash 0.06
Free Cash Flow 119.80
Particulars MAR 2022 (Values in Cr)
Net Income 19.00
Cash from Operations 35.52
Cash from Investing -90.37
Cash from Financing 54.62
Net change in Cash -0.05
Free Cash Flow 133.05
Particulars MAR 2021 (Values in Cr)
Net Income 13.23
Cash from Operations 15.30
Cash from Investing -46.83
Cash from Financing 32.03
Net change in Cash -0.22
Free Cash Flow 62.13
Particulars MAR 2020 (Values in Cr)
Net Income 12.22
Cash from Operations 21.63
Cash from Investing -22.40
Cash from Financing 3.48
Net change in Cash -0.06
Free Cash Flow 43.68
Particulars MAR 2024 (Values in Cr)
Net Income 15.89
Cash from Operations 141.82
Cash from Investing -51.53
Cash from Financing 27.44
Net change in Cash 0.37
Free Cash Flow 201.38
Particulars MAR 2023 (Values in Cr)
Net Income 16.87
Cash from Operations 37.60
Cash from Investing -74.37
Cash from Financing 41.09
Net change in Cash 0.06
Free Cash Flow 119.80
Particulars MAR 2022 (Values in Cr)
Net Income 19.00
Cash from Operations 35.59
Cash from Investing -90.40
Cash from Financing 54.56
Net change in Cash -0.05
Free Cash Flow 133.12
Particulars MAR 2021 (Values in Cr)
Net Income 13.24
Cash from Operations 15.31
Cash from Investing -46.83
Cash from Financing 32.03
Net change in Cash -0.21
Free Cash Flow 62.14
Particulars MAR 2020 (Values in Cr)
Net Income 12.22
Cash from Operations 21.56
Cash from Investing -22.33
Cash from Financing 3.48
Net change in Cash -0.07
Free Cash Flow 43.53
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 57.16 32.85 3.12 438.04 37.54 / 77.70
BLISS GVS PHARMA LTD 161.70 20.24 1.68 1702.73 92.25 / 165.00
CIPLA LTD 1534.40 26.84 4.36 123920.06 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 360.80 125.28 3.65 1061.87 145.00 / 399.60
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 57.16 49.70 9.71 438.04 37.54 / 77.70
AMRUTAJAN HEALTH LTD 739.00 44.95 7.17 2136.50 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6562.10 127.44 24.14 16405.25 4050.15 / 8139.85
BLISS GVS PHARMA LTD 161.70 21.05 1.66 1702.73 92.25 / 165.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 294.60
  • 26 Days 303.20
  • 10 Days 295.80
  • 50 Days 308.90
  • 12 Days 296.90
  • 100 Days 313.10
  • 20 Days 299.80
  • 200 Days 405.60
301.07
PIVOT
First Resistance 308.03
Second Resistance 312.92
Third Resistance 319.88
First Support 296.18
Second Support 289.22
Third Support 284.33
RSI 50.15
MACD -6.24
Commodity Channel Index (CCI) -17.45
ADX 20.74
Williams % R -41.90

Over 1 Month

down

-1.30

Over 3 Months

down

-1.39

Over 6 Months

down

-9.39

Over 1 Year

down

-23.62

Over 3 Years

down

29.03

Over 5 Years

down

42.19

SAKAR HEALTHCARE LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

SAKAR HEALTHCARE LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
33.42
Promoter Holdings
53.15
FII
13.42
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Sanjay S Shah Shareholding of Promoter and Promoter Group 9908543.0 45.56
Tata Capital Healthcare Fund Ii Public Shareholding 2309910.0 10.62
Hbm Healthcare Investments (cayman) Ltd Public Shareholding 1500000.0 6.9
Cobra India (mauritius) Limited Public Shareholding 1418886.0 6.52
Shah Aarsh Shareholding of Promoter and Promoter Group 1307500.0 6.01
Subhash Phootarmal Rathod Public Shareholding 520587.0 2.39
Hi-tech Chemicals Limited Public Shareholding 427358.0 1.96
Ritaben Shah Shareholding of Promoter and Promoter Group 245000.0 1.13
Shah Ayushi Shareholding of Promoter and Promoter Group 100000.0 0.46

SAKAR HEALTHCARE LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About SAKAR HEALTHCARE LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by SAKAR HEALTHCARE LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Sakar Healthcare Ltd?

Answer Field

The share price of Sakar Healthcare Ltd for NSE is ₹ 0 and for BSE is ₹ 0.00.

What is the Market Cap of Sakar Healthcare Ltd?

Answer Field

The market cap of Sakar Healthcare Ltd for NSE is ₹ 0.00 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Sakar Healthcare Ltd?

Answer Field

The 52 Week High and Low of Sakar Healthcare Ltd for NSE is ₹ 479.00 and ₹ 279.85 and for BSE is ₹ 0.00 and ₹ 0.00.

How to Buy Sakar Healthcare Ltd share?

Answer Field

You can trade in Sakar Healthcare Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Sakar Healthcare Ltd?

Answer Field

The 1 year returns on the stock has been -23.62%.

What is the Current Share Price of Sakar Healthcare Ltd?

Answer Field

Sakar Healthcare Ltd share price is for NSE ₹ 0 & for BSE ₹ 0.00 as on Dec 02 2024 12:00 AM.

What is the Market Cap of Sakar Healthcare Ltd Share?

Answer Field

The market cap of Sakar Healthcare Ltd for NSE ₹ 0.00 & for BSE ₹ 0.0 as on Dec 02 2024 12:00 AM.

What is the P/E Ratio of Sakar Healthcare Ltd Share?

Answer Field

As on Dec 02 2024 12:00 AM the price-to-earnings (PE) ratio for Sakar Healthcare Ltd share is 54.18.

What is the PB ratio of Sakar Healthcare Ltd Share?

Answer Field

As on Dec 02 2024 12:00 AM, the price-to-book (PB) ratio for Sakar Healthcare Ltd share is 123.91.

How to Buy Sakar Healthcare Ltd Share?

Answer Field

You can trade in Sakar Healthcare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Sakar Healthcare Ltd Share on Bajaj Broking App?

Answer Field

To buy Sakar Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sakar Healthcare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader